Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1984 1
1988 1
1991 3
1993 4
1994 1
1995 2
1996 2
1998 3
1999 2
2000 1
2002 3
2004 1
2006 1
2007 2
2008 1
2011 3
2012 1
2014 2
2017 4
2018 5
2019 7
2020 8
2021 10
2022 8
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

74 results

Results by year

Filters applied: . Clear all
Page 1
Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS.
Miller TM, Cudkowicz ME, Genge A, Shaw PJ, Sobue G, Bucelli RC, Chiò A, Van Damme P, Ludolph AC, Glass JD, Andrews JA, Babu S, Benatar M, McDermott CJ, Cochrane T, Chary S, Chew S, Zhu H, Wu F, Nestorov I, Graham D, Sun P, McNeill M, Fanning L, Ferguson TA, Fradette S; VALOR and OLE Working Group. Miller TM, et al. N Engl J Med. 2022 Sep 22;387(12):1099-1110. doi: 10.1056/NEJMoa2204705. N Engl J Med. 2022. PMID: 36129998 Free article. Clinical Trial.
Efficacy and safety of vutrisiran for patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: a randomized clinical trial.
Adams D, Tournev IL, Taylor MS, Coelho T, Planté-Bordeneuve V, Berk JL, González-Duarte A, Gillmore JD, Low SC, Sekijima Y, Obici L, Chen C, Badri P, Arum SM, Vest J, Polydefkis M; HELIOS-A Collaborators. Adams D, et al. Amyloid. 2023 Mar;30(1):1-9. doi: 10.1080/13506129.2022.2091985. Epub 2022 Jul 23. Amyloid. 2023. PMID: 35875890 Clinical Trial.
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study.
Howard JF Jr, Utsugisawa K, Benatar M, Murai H, Barohn RJ, Illa I, Jacob S, Vissing J, Burns TM, Kissel JT, Muppidi S, Nowak RJ, O'Brien F, Wang JJ, Mantegazza R; REGAIN Study Group. Howard JF Jr, et al. Lancet Neurol. 2017 Dec;16(12):976-986. doi: 10.1016/S1474-4422(17)30369-1. Epub 2017 Oct 20. Lancet Neurol. 2017. PMID: 29066163 Clinical Trial.
Long-term safety and efficacy of eculizumab in generalized myasthenia gravis.
Muppidi S, Utsugisawa K, Benatar M, Murai H, Barohn RJ, Illa I, Jacob S, Vissing J, Burns TM, Kissel JT, Nowak RJ, Andersen H, Casasnovas C, de Bleecker JL, Vu TH, Mantegazza R, O'Brien FL, Wang JJ, Fujita KP, Howard JF Jr; Regain Study Group. Muppidi S, et al. Muscle Nerve. 2019 Jul;60(1):14-24. doi: 10.1002/mus.26447. Epub 2019 Mar 8. Muscle Nerve. 2019. PMID: 30767274 Free PMC article.
Association between early nutrition support and 28-day mortality in critically ill patients: the FRANS prospective nutrition cohort study.
Pardo E, Lescot T, Preiser JC, Massanet P, Pons A, Jaber S, Fraipont V, Levesque E, Ichai C, Petit L, Tamion F, Taverny G, Boizeau P, Alberti C, Constantin JM, Bonnet MP; FRANS study group. Pardo E, et al. Crit Care. 2023 Jan 7;27(1):7. doi: 10.1186/s13054-022-04298-1. Crit Care. 2023. PMID: 36611211 Free PMC article.
Uncontrolled bleeding of the gastrointestinal tract.
D'Hondt A, Haentjens L, Brassart N, Flamme F, Preiser JC. D'Hondt A, et al. Curr Opin Crit Care. 2017 Dec;23(6):549-555. doi: 10.1097/MCC.0000000000000452. Curr Opin Crit Care. 2017. PMID: 28953556 Review.
Effect of high-dose vitamin D3 on 28-day mortality in adult critically ill patients with severe vitamin D deficiency: a study protocol of a multicentre, placebo-controlled double-blind phase III RCT (the VITDALIZE study).
Amrein K, Parekh D, Westphal S, Preiser JC, Berghold A, Riedl R, Eller P, Schellongowski P, Thickett D, Meybohm P; VITDALIZE Collaboration Group. Amrein K, et al. BMJ Open. 2019 Nov 12;9(11):e031083. doi: 10.1136/bmjopen-2019-031083. BMJ Open. 2019. PMID: 31722941 Free PMC article.
Postmortem fetal magnetic resonance imaging: where do we stand?
D'Hondt A, Cassart M, De Maubeuge R, Soto Ares G, Rommens J, Avni EF. D'Hondt A, et al. Insights Imaging. 2018 Aug;9(4):591-598. doi: 10.1007/s13244-018-0627-0. Epub 2018 Jun 4. Insights Imaging. 2018. PMID: 29869137 Free PMC article. Review.
Psychopathology in premanifest C9orf72 repeat expansion carriers.
De Vocht J, Stam D, Nicolini M, Lamaire N, Laroy M, Vande Casteele T, Van De Vliet L, Vansteelandt K, D'Hondt A, Emsell L, Bruffaerts R, Vandenbulcke M, van Damme P, Van den Stock J. De Vocht J, et al. Among authors: d hondt a. J Neurol Neurosurg Psychiatry. 2022 May;93(5):565-567. doi: 10.1136/jnnp-2021-327774. Epub 2021 Sep 28. J Neurol Neurosurg Psychiatry. 2022. PMID: 34583943 No abstract available.
74 results